  | EL HAYDERI, L., PAUROBALLY, D., FASSOTTE, M.-F., ARRESE ESTRADA, J., Sadzot-Delvaux, C., RUEBBEN, A., ANDRE, J., & NIKKELS, A. (2013). HERPES SIMPLEX VIRUS TYPE_i AND PYOGENIC GRANULOMA : A VASCULAR ENDOTHELIAL GROWTH FACTOR-MEDIATED ASSOCIATION? Case Reports in Dermatology, 5, 236-243. doi:10.1159/000354570  Peer Reviewed verified by ORBi |
  | Bonnet, C., DE PRIJCK, B., LEJEUNE, M., FASSOTTE, M.-F., Van Den Neste, E., & Beguin, Y. (2012). Prise en charge du lymphome B diffus à grandes cellules en 2012. Revue Médicale Suisse, 8, 1582-90. Peer Reviewed verified by ORBi |
 | Jaspers, A., Baron, F., Bonnet, C., De Prijck, B., Fassotte, M.-F., & Beguin, Y. (2010). Le lymphome du manteau. Revue Médicale de Liège, 65, 171-176. Peer reviewed |
 | Bisig, B., Copie-Bergman, C., Baia, M., Gaulard, P., Delbecque, K., Fassotte, M.-F., Boniver, J., & de Leval, L. (2009). Primary mucosa-associated lymphoid tissue lymphoma of the gallbladder: report of a case harboring API2/MALT1 gene fusion. Human Pathology, 40 (10), 1504-9. doi:10.1016/j.humpath.2009.02.018 Peer Reviewed verified by ORBi |
 | Lejeune, M., Beguin, Y., De Prijck, B., Fassotte, M.-F., Fillet, G., & Baron, F. (2008). Comment je traite...La leucémie myéloblastique aiguë (LMA) du sujet age en bon état général. Revue Médicale de Liège, 63 (2), 59-63. Peer reviewed |
 | Bonnet, C., Beguin, Y., Fassotte, M.-F., Seidel, L., Luyckx, F., & Fillet, G. (2007). Limited usefulness of CA125 measurement in the management of Hodgkin's and non-Hodgkin's lymphoma. European Journal of Haematology, 78 (5), 399-404. doi:10.1111/j.1600-0609.2007.00843.x Peer Reviewed verified by ORBi |
 | Thielen, C., Herens, C., Fassotte, M.-F., Detrooz, E., Drion, P., Diss, T., Boniver, J., & de Leval, L. (October 2006). Establishment and characterisation of two novel human KSHV- and EBV-negative Burkitt cell lines, GAL-01 and GAL-02, from a primary lymphomatous effusion. European Journal of Haematology, 77 (4), 318-326. doi:10.1111/j.1600-0609.2006.00724.x Peer Reviewed verified by ORBi |
 | Jerusalem, G., Silvestre, R., Beguin, Y., Hustinx, R., Fassotte, M.-F., & Fillet, G. (20 June 2006). FDG-PET for the routine follow-up in NHL: First prospective evaluation. Journal of Clinical Oncology, 24 (18, Part 1 Suppl. S), 439. Peer Reviewed verified by ORBi |
 | Bonnet, C., Beguin, Y., FASSOTTE, M.-F., & Fillet, G. (2006). Limited usefulness of CA 125 measurement in the management of hodgkin's and non-hodgkin's lymphomas [Poster presentation]. 21st General Meeting of the Belgian Hematological Society. |
 | Depas, G., De Barsy, C., Jerusalem, G., Hoyoux, C., DRESSE, M.-F., Fassotte, M.-F., Paquet, N., Willems, J., Rigo, P., & Hustinx, R. (January 2005). F-18-FDG PET in children with lymphomas. European Journal of Nuclear Medicine and Molecular Imaging, 32 (1), 31-38. doi:10.1007/s00259-004-1604-z Peer Reviewed verified by ORBi |
 | Dubuisson, A., Kaschten, B., Lenelle, J., Martin, D., Robe, P., Fassotte, M.-F., Rutten, I., Deprez, M., & Stevenaert, A. (2004). Primary central nervous system lymphoma - Report of 32 cases and review of the literature. Clinical Neurology and Neurosurgery, 107 (1), 55-63. doi:10.1016/j.clineuro.2004.03.005 Peer Reviewed verified by ORBi |
 | Delanaye, P., Bovy, C., de Leval, L., Fassotte, M.-F., Witvrouw, N., Dechenne, C., Tassin, F., & Krzesinski, J.-M. (2004). Back pain and renal failure. The Lancet, 364 (9449), 1992. doi:10.1016/S0140-6736(04)17484-9 Peer Reviewed verified by ORBi |
 | Hustinx, R., Lemaire, C., Jerusalem, G., Moreau, P., Cataldo, D., Duysinx, B., Aerts, J., Fassotte, M.-F., Foidart, J., & Luxen, A. (April 2003). Whole-body tumor imaging using PET and 2-18F-fluoro-l-tyrosine: Preliminary evaluation and comparison with 18F-FDG. Journal of Nuclear Medicine, 44 (4), 533-539. Peer Reviewed verified by ORBi |
 | Jerusalem, G., Beguin, Y., Fassotte, M.-F., Belhocine, T., Hustinx, R., Rigo, P., & Fillet, G. (2003). Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin's disease. Annals of Oncology, 14 (1), 123-30. doi:10.1093/annonc/mdg011 Peer Reviewed verified by ORBi |
 | Jerusalem, G., Hustinx, R., Beguin, Y., Depas, G., Fassotte, M.-F., De Barsy, C., Foidart, J., & Fillet, G. (2003). Les lymphomes. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 27 (8), 401-410. Peer reviewed |
 | Andre, M., Baudoux, E., Bron, D., Canon, J.-L., D'Hondt, V., Fassotte, M.-F., D'Hondt, L., Fillet, G., Humblet, Y., Jerusalem, G., Vermeulen, P., Symann, M., & Beguin, Y. (2003). Phase III randomized study comparing 5 or 10 microg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies. Transfusion, 43 (1), 50-7. doi:10.1046/j.1537-2995.2003.00273.x Peer Reviewed verified by ORBi |
 | DE BARSY, DEPAS, G., DRESSE, M.-F., HOYOUX, C., SCHMITZ, V., JERUSALEM, G., FASSOTTE, M.-F., FOIDART-WILLEMS, J., & HUSTINX, R. (2003). Whole-body FDG PET imaging as a method for staging and early assessment of treatment response in pediatric patients with lymphoma. Journal of Nuclear Medicine, 44, 183. Peer Reviewed verified by ORBi |
 | DE BARSY, DEPAS, G., DRESSE, M.-F., HOYOUX, C., SCHMITZ, V., JERUSALEM, G., FASSOTTE, M.-F., FOIDART-WILLEMS, J., & HUSTINX, R. (2003). Whole-body FDG PET in the follow-up of pediatric patients with lymphoma. Journal of Nuclear Medicine, 44, 346. Peer Reviewed verified by ORBi |
 | Warland, V., Jerusalem, G., Hustinx, R., Beguin, Y., Silvestre, R. M., Fassotte, M.-F., Foidart, J., & Fillet, G. (2002). Comment etablir le bilan de fin de traitement des patients atteints de lymphomes non-hodgkiniens (LNH) de malignite intermediaire ou elevee? Revue Médicale de Liège, 57 (12), 779-84. Peer reviewed |
 | Jerusalem, G., Beguin, Y., Najjar, F., Hustinx, R., Fassotte, M.-F., Rigo, P., & Fillet, G. (2001). Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL). Annals of Oncology, 12 (6), 825-30. doi:10.1023/A:1011169332265 Peer Reviewed verified by ORBi |
 | Jerusalem, G., Beguin, Y., Fassotte, M.-F., Najjar, F., Paulus, P., Rigo, P., & Fillet, G. (2001). Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease. Haematologica, 86 (3), 266-73. Peer Reviewed verified by ORBi |
 | BELHOCINE, T., HUSTINX, R., JERUSALEM, G., FASSOTTE, M.-F., DUYSINX, B., QUADEN, C., & RIGO, P. (2000). 99mTc rh-Annexin V (ApomateTM) as a marker of apoptosis resulting from chemotherapy : preliminary results. Journal of Nuclear Medicine, 41 (SUPPL), 263. Peer Reviewed verified by ORBi |
 | Fraipont, V., Sautois, B., Baudoux, E., Pereira-Martins, M., Fassotte, M.-F., Hermanne, J. P., Jerusalem, G., Longree, L., Schaaf-Lafontaine, N., Fillet, G., & Beguin, Y. (2000). Successful mobilization of peripheral blood HPCs with G-CSF alone in patients failing to achieve sufficient numbers of CD34+ cells and/or CFU-GM with chemotherapy and G-CSF. Transfusion, 40 (3), 339-47. doi:10.1046/j.1537-2995.2000.40030339.x Peer Reviewed verified by ORBi |
 | Jerusalem, G., Beguin, Y., Fassotte, M.-F., Najjar, F., Paulus, P., Rigo, P., & Fillet, G. (2000). Persistent tumor 18F-FDG uptake after a few cycles of polychemotherapy is predictive of treatment failure in non-Hodgkin's lymphoma. Haematologica, 85 (6), 613-8. Peer Reviewed verified by ORBi |
 | Jerusalem, G., Beguin, Y., Fassotte, M.-F., Belhocine, T., Najjar, F., Hustinx, R., Rigo, P., & Fillet, G. (2000). Evaluation thérapeutique précoce par tomographie à émission de positons. Médecine et Hygiène, 58, 1629-1632. Peer Reviewed verified by ORBi |
 | Baudoux, E., Blaffart, F., Bouffioux, C., Caprasse, M., Courtois, F., Cremasco, M.-R., De Pasqual, E., Fassotte, M.-F., Gillet, P., Lamy, M., Larbuisson, R., Lemaire, R., Merciny, M., Moutschen, M., Radermecker, M., Remy, B., & Sondag, D. (2000). La commission d'hemovigilance du CHU. Revue Médicale de Liège, 55 (9), 878-80. Peer reviewed |
 | JERUSALEM, G., BEGUIN, Y., FASSOTTE, M.-F., BELHOCINE, T., HUSTINX, R., RIGO, P., & FILLET, G. (2000). Early detection of relapse by whole-body positron emission tomography (PET) using 18F-fluorodeoxyglucose (18F-FDG) in the follow-up of patients with Hodgkin’s disease (HD). PROCEEDINGS OF AMERICAN SOCIETY OF CLINICAL ONCOLOGY ANNUAL MEETING 2000, 19, 10. Peer reviewed |
 | Sautois, B., Fraipont, V., Baudoux, E., Fassotte, M.-F., Hermanne, J. P., Jerusalem, G., Bours, V., Bosquee, L., Schaaf-Lafontaine, N., Paulus, J.-M., Sondag, D., Fillet, G., & Beguin, Y. (1999). Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields. Haematologica, 84 (4), 342-9. Peer Reviewed verified by ORBi |
 | Nikkels, A., Frere, P., Rakic, L., Fassotte, M.-F., Evrard, B., De Mol, P., & Pierard, G. (1999). Simultaneous Reactivation of Herpes Simplex Virus and Varicella-Zoster Virus in a Patient with Idiopathic Thrombocytopenic Purpura. Dermatology, 199 (4), 361-364. doi:10.1159/000018292 Peer Reviewed verified by ORBi |
 | Jerusalem, G., Beguin, Y., Fassotte, M.-F., Najjar, F., Paulus, P., Rigo, P., & Fillet, G. (1999). Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging. Blood, 94 (2), 429-33. doi:10.1182/blood.v94.2.429.414k26_429_433 Peer Reviewed verified by ORBi |
 | Herens, C., Hermanne, J.-P., Tassin, F., Fassotte, M.-F., Thiry, A., Jamar, M., Schaaf-Lafontaine, N., Fillet, G., & Koulischer, L. (1999). Translocation (2;3)(p21;q26) as the sole anomaly in a case of primary myelofibrosis. Cancer Genetics and Cytogenetics, 110 (1), 62-4. doi:10.1016/S0165-4608(98)00186-1 Peer Reviewed verified by ORBi |
 | Baron, F., Hermanne, J.-P., Dowlati, A., Weber, T., Thiry, A., Fassotte, M.-F., Fillet, G., & Beguin, Y. (1998). Bronchiolitis obliterans organizing pneumonia and ulcerative colitis after allogeneic bone marrow transplantation. Bone Marrow Transplantation, 21 (9), 951-4. doi:10.1038/sj.bmt.1701198 Peer Reviewed verified by ORBi |
Baron, F., Hermanne, J. P., Fassotte, M.-F., Beguin, Y., & Fillet, G. (1998). Le cas clinique du mois. Association d'une maladie de Hodgkin et d'un syndrome nephrotique. Revue Médicale de Liège, 53 (11), 651-3. Peer reviewed |
FRANCHIMONT, D., Freres, P., LEBRUN, F., FASSOTTE, M.-F., & D'Orio, V. (1996). Le cas clinique du mois : syndrome de Moskowitz chez un patient traité par ticlopidine. Revue Médicale de Liège, 51 (3), 214-216. Peer reviewed |
 | Jerusalem, G., Detroz, B., Herman, P., Dohogne, A., Closon, M. T., Jacquet, N., Honoré, P., Bruyninx, L., Fillet, G., Fassotte, M.-F., Bours, V., & Lipcsei, G. (1995). Approche thérapeutique du cancer épithélial de l'ovaire au CHU Sart Tilman : Conclusions de la réunion interdisciplinaire du 22 mars 1995. Revue Médicale de Liège, 50, 469-471. Peer reviewed |
De Groote, D., Zangerlé, P.-F., Gevaert, Y., Fassotte, M.-F., Beguin, Y., Noizat-Pirenne, F., Pirenne, J., Gathy, R., Lopez Y Cadenas, M., & Dehart, I. (1992). Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine, 4 (3), 239-48. doi:10.1016/1043-4666(92)90062-V Peer Reviewed verified by ORBi |
 | Sautois, B., Mélon, P., Grek, V., Fassotte, M.-F., & Fillet, G. (1991). Thrombocytopénie allergique à la nitrofurantoïne. Revue Médicale de Liège, 46, 592. Peer reviewed |
 | Andrien, F., Fassotte, M.-F., Beguin, Y., & Fillet, G. (1990). Traitement des lymphomes non hodgkiniens : de l'abstention thérapeutique à la greffe de moelle. Médecine et Hygiène, 48, 3672-3676. Peer Reviewed verified by ORBi |
Beguin, Y., Fassotte, M.-F., Hay, F., Dokekias, A., Andrien, F., Bours, V., Moutschen, M., Runde, V., Bury, J., & Fillet, G. (1990). Greffes de moelle osseuse: bilan au CHU de Liege. Revue Médicale de Liège, 45 (6), 268-79. Peer reviewed |
 | Fassotte, M.-F., Beguin, Y., Andrien, F., & Fillet, G. (1990). Allogreffes et autogreffes de moelle osseuse. Indications, résultats, perspectives. Médecine et Hygiène, 48, 3666-3671. Peer Reviewed verified by ORBi |
FASSOTTE, M.-F., Bury, T., & Radermecker, M. (1987). Increase of natural killer cell activity in allergic asthma. Clinical Respiratory Physiology, 23 (S12), 376. Peer reviewed |